The results are very encouraging news for Amgen and Repatha, which is in a head-to-head marketing battle with Sanofi and Regeneron’s Praluent to be the dominant PCSK9 inhibitor. Both drugs have ...

Repatha (evolocumab) is a human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove LDL-C, or 'bad' cholesterol, from the blood.

CHICAGO, IL—Patients with stable CAD who respond well to the PCSK9 inhibitor evolocumab (Repatha; Amgen) have differences in gene expression compared with nonresponders, according to new data from the ...

NewAmsterdam Pharma said Tuesday its cholesterol drug lowered the risk of major cardiovascular events and the biotech stock ...

Inject Repatha only on the day of your scheduled dose, not a day early. But you may be able to shift your usual injection time of day. Repatha has received Food and Drug Administration (FDA ...

Dutch clinical-stage drug developer NewAmsterdam Pharma saw its shares close up 41% at $26.19 yesterday on positive research ...

In adults with cardiovascualr disease or high cholesterol, doctors prescribe subcutaneous (below the skin) Repatha injections every 2 weeks or monthly. To find out if a Medicare plan covers ...

Repatha, approved by regulators in 2015, belongs to a class of injected antibody drugs that target PCSK9, a protein that maintains "bad" LDL cholesterol in the blood. It is aimed at the millions ...